Ascension Via Christi says its supply of blood plasma has been depleted in Wichita

Ascension Via Christi said Aug. 5 that its supply of convalescent plasma has been depleted in its Wichita, Kan., hospitals, The Wichita Eagle reported.

Advertisement

Convalescent plasma is collected from people who have recovered from COVID-19 and have antibodies that could treat people infected with the disease. 

The American Red Cross announced a shortage of plasma last month. 

Laura Potter, supervisor of the Ascension Via Christi St. Francis Blood Bank, told The Wichita Eagle that the blood bank hasn’t received plasma in five days, but the hospital has several patients waiting for it. 

Wichita, Kan.-based Ascension Via Christi said it’s used convalescent plasma in more than 80 adult COVID-19 patients in its Wichita hospitals and  has four patients waiting for plasma, all of whom either have severe or life-threatening COVID-19 or have been deemed as high risk for progression to that stage of the disease, according to The Wichita Eagle. 

Janie Krull, director of research for Ascension Via Christi, said most patients who have been treated with convalescent plasma at Ascension’s hospitals have recovered well enough to be discharged. 

Read the full article here.

More articles on supply chain:
Gov. Newsom clashes with California hospital association over state’s mask supply
FDA allowed hundreds of mask brands to be sold in US with little oversight, analysis finds
FTC sues 3 online PPE sellers, alleging deceptive practices

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.